Your browser is no longer supported. Please, upgrade your browser.
OpGen, Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own0.05% Shs Outstand38.27M Perf Week-5.60%
Market Cap98.64M Forward P/E- EPS next Y-0.46 Insider Trans-7.67% Shs Float36.02M Perf Month-15.38%
Income-26.20M PEG- EPS next Q-0.24 Inst Own2.70% Short Float2.42% Perf Quarter15.00%
Sales4.20M P/S23.49 EPS this Y78.40% Inst Trans2.63% Short Ratio0.08 Perf Half Y4.98%
Book/sh1.00 P/B2.53 EPS next Y40.00% ROA-65.30% Target Price- Perf Year8.12%
Cash/sh0.34 P/C7.36 EPS next 5Y- ROE-147.50% 52W Range1.63 - 4.44 Perf YTD24.02%
Dividend- P/FCF- EPS past 5Y70.20% ROI-52.80% 52W High-43.02% Beta-0.42
Dividend %- Quick Ratio2.10 Sales past 5Y5.90% Gross Margin8.70% 52W Low55.21% ATR0.27
Employees94 Current Ratio2.30 Sales Q/Q75.00% Oper. Margin- RSI (14)44.94 Volatility4.71% 7.33%
OptionableNo Debt/Eq0.96 EPS Q/Q43.50% Profit Margin- Rel Volume0.07 Prev Close2.56
ShortableYes LT Debt/Eq0.92 EarningsMar 25 AMC Payout- Avg Volume11.62M Price2.53
Recom2.00 SMA20-7.43% SMA50-5.63% SMA20010.70% Volume861,378 Change-1.17%
Mar-01-19Initiated Alliance Global Partners Buy $2.30
Feb-07-18Reiterated H.C. Wainwright Buy $1 → $9
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Apr-12-21 07:30AM  
Mar-26-21 03:28AM  
Mar-25-21 05:25PM  
Mar-24-21 10:04AM  
Mar-18-21 12:30PM  
Mar-11-21 07:30AM  
Mar-09-21 08:03AM  
Mar-08-21 07:30AM  
Mar-01-21 07:30AM  
Feb-22-21 09:47AM  
Feb-16-21 07:30AM  
Feb-09-21 08:30AM  
Jan-13-21 11:02AM  
Jan-11-21 10:11AM  
Jan-05-21 07:30AM  
Dec-17-20 08:00AM  
Dec-09-20 07:30AM  
Dec-01-20 07:30AM  
Nov-24-20 08:00AM  
Nov-12-20 07:30AM  
Nov-11-20 04:05PM  
Oct-29-20 07:30AM  
Oct-28-20 07:30AM  
Oct-26-20 09:51AM  
Oct-15-20 07:30AM  
Oct-14-20 07:53AM  
Oct-13-20 05:00PM  
Oct-12-20 10:19AM  
Oct-05-20 08:19AM  
Sep-30-20 07:30AM  
Sep-28-20 07:30AM  
Sep-18-20 04:30PM  
Sep-16-20 07:30AM  
Sep-08-20 07:30AM  
Sep-02-20 07:30AM  
Aug-31-20 08:41AM  
Aug-20-20 01:26PM  
Aug-12-20 04:33PM  
Aug-11-20 10:30AM  
Aug-09-20 04:15PM  
Aug-05-20 07:30AM  
Jul-15-20 07:30AM  
Jul-13-20 08:30AM  
Jul-09-20 11:59AM  
Jun-16-20 08:47AM  
Jun-09-20 10:28AM  
Jun-03-20 06:00AM  
May-11-20 07:30AM  
May-07-20 04:05PM  
Apr-27-20 08:30AM  
Apr-21-20 09:00AM  
Apr-16-20 07:30AM  
Apr-14-20 07:30AM  
Apr-05-20 01:17AM  
Apr-02-20 07:57AM  
Apr-01-20 04:00PM  
Mar-30-20 10:50AM  
Mar-24-20 04:05PM  
Mar-23-20 07:30AM  
Mar-19-20 09:00AM  
Mar-16-20 01:49PM  
Mar-12-20 07:30AM  
Mar-10-20 11:00AM  
Feb-20-20 09:40AM  
Feb-12-20 10:10AM  
Jan-30-20 08:21AM  
Jan-28-20 07:30AM  
Jan-13-20 10:12AM  
Dec-23-19 07:30AM  
Dec-06-19 09:18AM  
Dec-05-19 06:21AM  
Dec-02-19 07:30AM  
Nov-19-19 07:30AM  
Nov-15-19 04:29PM  
Nov-06-19 08:55PM  
Nov-04-19 07:30AM  
Oct-30-19 10:33AM  
Oct-29-19 04:05PM  
Oct-28-19 11:51AM  
Oct-25-19 07:12AM  
Oct-24-19 07:36AM  
Oct-23-19 11:16PM  
Oct-07-19 07:30AM  
Sep-26-19 07:30AM  
Sep-19-19 02:59PM  
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen; and QuickFISH and PNA FISH diagnostic test products for the identification of various infectious pathogens, as well as SARS CoV-2 test kits. In addition, it offers Acuitas Lighthouse informatics systems, a cloud-based HIPAA compliant informatics, which combines clinical lab test results with patient and hospital information to provide analytics and insights to enable manage MDROs in the hospital and patient care environment; Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers; and ARES Technology Platform, including ARESdb, which provides next generation sequencing based and artificial intelligence powered, cloud-based bioinformatics solutions to generate AMR profiles, as well as predict antimicrobial susceptibility test results. OpGen, Inc. has a strategic collaboration with the New York State Department of Health to develop a solution to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JONES EVAN/ FADirectorOct 27Sale2.351,7484,10821,734Oct 29 04:33 PM
JONES EVAN/ FADirectorSep 04Sale2.193,6127,91023,482Sep 09 05:31 PM
JONES EVAN/ FADirectorMay 17Option Exercise0.00883027,094May 19 08:37 PM
DEC TIMOTHY CChief Financial OfficerMay 17Option Exercise0.005830926May 19 08:36 PM
Curetis N.V. in Liquidation10% OwnerMay 07Sale2.2019420May 11 02:35 PM
Curetis N.V. in Liquidation10% OwnerApr 23Sale2.1746,612101,1481,622,568Apr 24 09:31 AM
Curetis N.V. in Liquidation10% OwnerApr 22Sale2.2442,37594,9201,669,180Apr 24 09:31 AM
Curetis N.V. in Liquidation10% OwnerApr 21Sale2.3095,609219,9011,711,555Apr 21 08:09 PM
Curetis N.V. in Liquidation10% OwnerApr 20Sale2.3555,142129,5841,807,164Apr 21 08:09 PM
Curetis N.V. in Liquidation10% OwnerApr 17Sale2.46165,902408,1191,862,306Apr 21 08:09 PM